PERFORMANCE OF A NOVEL GENETIC RISK SCORE TO IDENTIFY RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CARDIOMETABOLIC DISEASE

Venous thromboembolism (VTE) is the third leading cause of CV mortality and has an established genetic predisposition. We tested the performance of a 10-SNP genetic risk score (GRS) for its ability to predict VTE in 3 TIMI trials. We included patients from the FOURIER, PEGASUS-TIMI 54, and SAVOR-